Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance, amount at Dec. 31, 2019 $ (27,632,622) $ 18,018 $ 5,795,636 $ (33,446,276)  
Beginning balance, shares at Dec. 31, 2019   18,017,944      
Net income 116,605     116,605  
Stock options exercised 7,500 $ 25 7,475    
Stock options exercised, share   25,000      
Share-based compensation 157,596 $ 63 157,533    
Share based compensation, share   63,333      
Ending balance, amount at Mar. 31, 2020 (27,350,921) $ 18,106 5,960,644 (33,329,671)  
Ending balance, shares at Mar. 31, 2020   18,106,277      
Beginning balance, amount at Dec. 31, 2020 (24,796,965) $ 21,971 10,798,536 (35,655,163) $ 37,691
Beginning balance, shares at Dec. 31, 2020   21,970,638      
Net income 88,737     88,737  
Foreign currency translation (79,207)       (79,207)
Stock options exercised 10,999 $ 50 10,949    
Stock options exercised, share   50,000      
Share-based compensation 316,640 $ 55 316,585    
Share based compensation, share   55,000      
Ending balance, amount at Mar. 31, 2021 $ (24,459,796) $ 22,076 $ 11,126,070 $ (35,566,426) $ (41,516)
Ending balance, shares at Mar. 31, 2021   22,075,638